SCHEMBL17501640

SCHEMBL17501640

Clc1cc2ccnc(-c3ccnn3C3CCCCO3)c2nc1N1CCOCC1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29398052 0.89 ATR (0.70) ATR
SCHEMBL17501623 0.86 ATR (0.65) ATR
SCHEMBL17501341 0.82 ATR (1.00) ATR
SCHEMBL17501054 0.82 ATR (0.80) ATR
SCHEMBL20081985 0.78 ATR (0.90) ATR
SCHEMBL17501105 0.78 ATR (0.71) ATR
SCHEMBL29398729 0.77 ATR (0.68) ATR
SCHEMBL17501336 0.77 ATR (1.00) ATR
SCHEMBL20081880 0.77 ATR (0.80) ATR
SCHEMBL17501071 0.77 ATR (0.80) ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177619-A1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES Bayer Pharma Aktiengesellschaft (DE) 2017-06-14 — — EP disclosed
WO-2016020320-A1 2-(MORPHOLIN-4-YL)-L,7-NAPHTHYRIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-02-11 — — WO disclosed
Send feedback